Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hélène Kolesnikov-Gauthier"'
Autor:
Pascal Chastagner, Olivier Cougnenc, Aurore Oudoux, Gudrun Schleiermacher, Dominique Valteau-Couanet, Stéphanie Proust, Isabelle Ferry, Hélène Kolesnikov-Gauthier, Jean Michon, Anne-Sophie Defachelles, Emilie Bogart
Publikováno v:
Journal of Pediatric Hematology/Oncology. 40:426-432
High-risk neuroblastoma is characterized by poor long-term survival, especially for very high-risk (VHR) patients (poor response of metastases after induction therapy). The benefits of a tandem high-dose therapy and hematologic stem cell reinfusion (
Autor:
Hélène Kolesnikov-Gauthier, Aurore Oudoux, Nathalie Lemoine, Emmanuelle Tresch-Bruneel, Nicolas Penel, Anais Olivier
Publikováno v:
Supportive Care in Cancer. 26:751-758
The purpose of this study is to assess the efficacy of 153Sm-EDTMP (Quadramet®) in a clinical setting. We have conducted a retrospective study of all consecutive patients (pts) treated with 153Sm-EDTMP for painful bone metastases. At each visit (bef
Autor:
Romain Modzelewski, Mathieu Salaün, Fabrice Denis, Naji Salem, Pierre Bohn, Jean-Pierre Muratet, Pierre Olivier, Sophie Guillemard, Nicolas Aide, Enrique Chajon, Laurent Vervueren, Pierre Vera, Alina Berriolo Riedinger, Claire Houzard, Marie Lacombe, Françoise Mornex, Etienne Martin, Maximilien Vermandel, Nathalie Charrier, P.O. Kotzki, Frédéric Courbon, Anne Devillers, Véronique Beckendorf, S. Danhier, Carole Massabeau, Marc-André Mahé, Eric Dansin, P. Boisselier, Philippe Chaumet-Riffaud, Philippe Fernandez, Sébastien Thureau, Amaury Paumier, Marie-Pierre Farcy Jacquet, Hélène Kolesnikov-Gauthier, Amandine Pallardy, Sébastien Hapdey, Bernard Dubray
Publikováno v:
Journal of Nuclear Medicine
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2017, 58 (7), pp.1045-1053. ⟨10.2967/jnumed.116.188367⟩
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2017, 58 (7), pp.1045-1053. ⟨10.2967/jnumed.116.188367⟩
International audience; See an invited perspective on this article on page 1043.This multicenter phase II study investigated a selective radiotherapy dose increase to tumor areas with significant (18)F-misonidazole ((18)F-FMISO) uptake in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616dab3ce564f41eff77bb14c5cd4f37
https://hal.archives-ouvertes.fr/hal-01643968
https://hal.archives-ouvertes.fr/hal-01643968
Autor:
Eric Dansin, Thomas Boulanger, Fabrice Narducci, Stephanie Petit, Isabelle Farre, Hélène Kolesnikov-Gauthier, Ecaterina Surmei-Pintilie, Henri Porte
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 2, Pp 422-425 (2014)
Case Reports in Oncology
Case Reports in Oncology
Thymic epithelial tumors are rare and often occur somewhere local. Metastatic sites of thymic carcinomas (Masaoka-Koga stage IVb) are mostly seen in the lung, liver and brain. We report a 64-year-old female with an initial diagnosis of thymoma B3 who
Publikováno v:
Imagerie de la Femme. 23:199-208
Resume Le traitement par radio-chimiotherapie concomitante suivie d’une curietherapie a change le pronostic des cancers du col uterin. L’IRM joue un role essentiel dans l’evaluation de la reponse au traitement en premiere intention. Cependant,
Autor:
Nicolas Aide, Claire Houzard, Jean Marc Caignon, Isabelle Brenot-Rossi, Romain Modzelewski, Eric Gremillet, Florent Cachin, Bernard Dubray, Alina Berriolo-Riedinger, B. Bridji, Philippe Chaumet-Riffaud, Laurent Tessonnier, Anne Devillers, Hélène Kolesnikov-Gauthier, Laurent Collombier, Philippe Fernandez, Pierre Vera, Pierre Olivier, Frédéric Courbon, Laurent Vervueren, Julie Roux, Oleg Blagosklonov, Sébastien Thureau, Kaya Doyeux
Publikováno v:
Journal of Nuclear Medicine. 54:1543-1550
As the preparation phase of a multicenter clinical trial using (18)F-fluoro-2-deoxy-d-glucose ((18)F-FDG), (18)F-fluoromisonidazole ((18)F-FMISO), and 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in non-small cell lung cancer (NSCLC) patients, we in
Publikováno v:
Imagerie de la Femme. 23:15-20
Resume Les objectifs du suivi post-therapeutique en imagerie dans le cancer de l’ovaire sont : l’evaluation de l’evolution sous chimiotherapie neoadjuvante, la recherche d’une recidive et sa caracterisation en vue de preciser les possibilites
Publikováno v:
Bulletin du Cancer. 99:21-28
FDG-PET is widely used for the diagnosis, the staging and the search for recurrence of many tumors. However, there are currently no recommendations for its use in endometrial cancer. This article is an update of the literature data to enable everyone
Autor:
Philippe Vennin, Jacques Bonneterre, Charles Fournier, Marie-Christine Baranzelli, V. Servent, Laurence Vanlemmens, P Carpentier, Hélène Kolesnikov-Gauthier
Publikováno v:
Breast Cancer Research and Treatment. 131:517-525
The aim of this study was to prospectively evaluate the predictive value of (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) to detect the absence of pathological response to preoperative chemotherapy in patients (pts) with breast canc
Publikováno v:
Bulletin du Cancer. 98:501-514
FDG-PET has boomed in recent years for diagnosis, staging and the search for recurrence of a large number of tumors. This is particularly true for soft tissue sarcomas and musculoskeletal sarcomas, for which the first publications on the potential ro